4865 results for "*oma"

in 21.21 milliseconds.

• H3K27ac ChIP-seq in Insulinomas

  H3K27ac ChIP-seq datasets in human insulinoma samples

  Dataset EGAD50000000461

• RNA-seq in insulinomas

  RNA-seq datasets in human insulinoma samples

  Dataset EGAD50000000462

• WGS in insulinomas

  Whole-Genome Sequencing datasets of insulinoma samples and paired blood controls

  Dataset EGAD50000000464

• CATNON: IDH-mutant astroctyoma RNA FASTQ

  Raw fastq files obtained by RNA sequencing 138 IDH-mutant astrocytomas included in the CATNON trial. RNA was extracted from formalin-fixed paraffin-embedded (FFPE) tissue blocks using the RNeasy FFPE kit. RNA sequencing was performed on an Illumina NovaSeq 6000 (GenomeScan BV, Leiden, The Netherlands) with 150bp paired-end reads including UMI tags.

  Dataset EGAD50000000558

• ONT sequencing of primary neuroblastoma samples

  Shallow WGS long-read sequencing of primary neuroblastoma samples.

  Dataset EGAD50000000508

• ONT sequencing neuroblastoma cell lines

  Shallow long-read nanopore WGS of ecDNA containing neuroblastoma cell lines.

  Dataset EGAD50000000509

• Paediatric neuroblastoma long-read whole genome sequencing dataset

  Dac EGAC50000000221

• A5_SDHB_PCPG_Methylation

  Illumina Infinium MethylationEPIC Array profiling of 93 pheochromocytoma and paraganglioma tumours with and a germline SDHB mutation

  Dataset EGAD00010002667

• Anti-tumor and Immune Stimulatory Activity of Iberdomide in Myeloma, Including Patients with Cereblon Dysregulation

  Study showing Iberdomide treatment leads to immune stimulation and shift to effector T cells in triple-class refractory patients and directly after IMiD therapy. This is the first clinical evidence that Iberdomide can overcome Cereblon defects associated with IMiD resistance in late-line myeloma patients.

  Study EGAS50000000265

• MD Anderson Lymphoma & Myeloma Data Access Committee

  Dac EGAC00001002706